We featured findings from our 2024 global oncology patient research, applying our behavioural science approach to understanding and improving adherence in self-administered cancer treatment.

Through a cross-sectional survey of adults with cancer, we identified four key behavioural drivers of intentional nonadherence:

• sensitivity to medicines

• testing treatment

• inconvenience

• resisting illness and medication 

Our analysis demonstrated that these factors are highly prevalent among nonadherent patients, highlighting the need for tailored, person-centred interventions to optimise health-related behaviours.

We proposed Acceptance and Commitment Therapy (ACT) as a promising and flexible framework that has evidence of effectiveness applied to cancer patients and carers, with processes designed to address openness to treatment doubts, mindful engagement with routines, and values-based action despite illness.

The findings emphasise the importance of understanding the psychological factors and individual motivations that support medication adherence. Conference attendees recognised the value of our work in advancing personalised strategies for oncology care, underscoring the potential impact of behavioural science in improving patient outcomes in oncology.

To discuss the research in more detail and receive a copy of our Treatment Motivators analysis, contact kate.perry@atlantishealth.com